Loading…
H.R. 1266119th Congress
The plain-language version leads. The official text is always the reference.
HR 1266 would make xylazine a Schedule III controlled substance while preserving legal veterinary access.
30-second read · 4 questions answered below
The bill classifies xylazine, an animal sedative increasingly found mixed into illegal drugs like fentanyl, as a Schedule III controlled substance. It preserves legal access for veterinary use and gives manufacturers and practitioners transition periods of 60 days to a year before new labeling, recordkeeping, and registration rules take effect.
Veterinarians, pharmacies, animal owners, animal-control and wildlife programs, drug manufacturers, and law enforcement are directly affected; communities facing the opioid crisis are indirectly affected.
Xylazine contamination makes overdoses harder to reverse with standard treatments like naloxone, prompting tighter federal controls alongside continued legal veterinary use.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.